Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.
About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine.
Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation.
UPDATED: He’s picking Nicole B. Saphier, MD, a board-certified breast specialist with Memorial Sloan Kettering Cancer Center and Fox News contributor, to fill the key role.
Mina Chung, MD, who just concluded a one-year term as Heart Rhythm Society's president, spoke to Cardiovascular Business about successes from the past year as well as her goals for the future.
Researchers tracked real-world data from 600 TAVR patients, following each one for approximately five years. Survival rates were similar for men and women early on, but then women started experiencing better outcomes after three years.
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Nursing technology leaders at a large health system are reporting time savings of 20.6 minutes per nurse across 12-hour shifts while caring for an average of 4.5 patients each. The secret to their success: automated digital documentation.
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
